Literature DB >> 17044024

The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease.

Juhua Luo1, Caroline Nordenvall, Olof Nyrén, Hans-Olov Adami, Johan Permert, Weimin Ye.   

Abstract

Although Helicobacter pylori (H. pylori) seropositivity is linked to an excess risk of pancreatic cancer, the biologic mechanism is unknown. Gastric ulcer is primarily associated with corpus colonization of H. pylori, atrophic gastritis and formation of N-nitrosamines. Duodenal ulcer is a marker of antral colonization, hyperacidity and uninhibited secretin release. We estimated relative risks for pancreatic cancer among patients with gastric or duodenal ulcer, based on a register-based retrospective cohort study with 88,338 patients hospitalized for gastric ulcer and 70,516 patients for duodenal ulcer recorded in the Swedish Inpatient Register between 1965 and 2003. Following operation, the 14,887 patients who underwent gastric resection and 8,205 with vagotomy were analyzed separately. Multiple record-linkages allowed complete follow-up and identification of all incident cases of pancreatic cancer until December 31, 2003. Standardized incidence ratios (SIRs) estimated relative risks. During years 3-38 of follow-up, we observed a 20% excess risk (95% confidence interval [CI] 10-40%) for pancreatic cancer among unoperated gastric ulcer patients. The excess increased to 50% (95% CI 10-110%) 15 years after first hospitalization (p for trend = 0.03). SIR was 2.1 (95% CI 1.4-3.1) 20 years after gastric resection. Unoperated duodenal ulcer was not associated with pancreatic cancer risk, nor was vagotomy. Our results lend indirect support to the nitrosamine hypothesis, but not to the hyperacidity hypothesis in the etiology of pancreatic cancer. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17044024     DOI: 10.1002/ijc.22123

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

Review 2.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  History of peptic ulcer disease and pancreatic cancer risk in men.

Authors:  Ying Bao; Donna Spiegelman; Ruifeng Li; Edward Giovannucci; Charles S Fuchs; Dominique S Michaud
Journal:  Gastroenterology       Date:  2009-10-07       Impact factor: 22.682

4.  Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.

Authors:  Adeyinka O Laiyemo; Farin Kamangar; Pamela M Marcus; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol       Date:  2009-10-01       Impact factor: 2.984

Review 5.  Role of bacterial infections in pancreatic cancer.

Authors:  Dominique S Michaud
Journal:  Carcinogenesis       Date:  2013-07-10       Impact factor: 4.944

6.  Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  C Bosetti; E Lucenteforte; P M Bracci; E Negri; R E Neale; H A Risch; S H Olson; S Gallinger; A B Miller; H B Bueno-de-Mesquita; R Talamini; J Polesel; P Ghadirian; P A Baghurst; W Zatonski; E Fontham; E A Holly; Y T Gao; H Yu; R C Kurtz; M Cotterchio; P Maisonneuve; M P Zeegers; E J Duell; P Boffetta; C La Vecchia
Journal:  Ann Oncol       Date:  2013-08-22       Impact factor: 32.976

7.  Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.

Authors:  Jiaqi Huang; Ulrika Zagai; Göran Hallmans; Olof Nyrén; Lars Engstrand; Rachael Stolzenberg-Solomon; Eric J Duell; Kim Overvad; Verena A Katzke; Rudolf Kaaks; Mazda Jenab; Jin Young Park; Raul Murillo; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Kathryn E Bradbury; Elio Riboli; Dagfinn Aune; Konstantinos K Tsilidis; Gabriel Capellá; Antonio Agudo; Vittorio Krogh; Domenico Palli; Salvatore Panico; Elisabete Weiderpass; Anne Tjønneland; Anja Olsen; Begoña Martínez; Daniel Redondo-Sanchez; Maria-Dolores Chirlaque; Petra Hm Peeters; Sara Regnér; Björn Lindkvist; Alessio Naccarati; Eva Ardanaz; Nerea Larrañaga; Marie-Christine Boutron-Ruault; Vinciane Rebours; Amélie Barré; H B As Bueno-de-Mesquita; Weimin Ye
Journal:  Int J Cancer       Date:  2017-04-15       Impact factor: 7.396

8.  Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Authors:  M C Bradley; L J Murray; M M Cantwell; C M Hughes
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

9.  The association of Helicobacter pylori with pancreatic cancer.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  GastroHep       Date:  2020-05-05

10.  A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.

Authors:  Björn Lindkvist; Dorthe Johansen; Anders Borgström; Jonas Manjer
Journal:  BMC Cancer       Date:  2008-11-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.